What are Delcath Systems's total assets?

Delcath Systems (DCTH) holds $124.8M in total assets, up 43.0% year over year.

How much debt does Delcath Systems have?

Delcath Systems carries $907.0K in total debt against $112.7M of shareholders' equity, a debt-to-equity ratio of 0.01.

How much cash does Delcath Systems have?

Delcath Systems holds $41.3M in cash and equivalents.

Can Delcath Systems cover its short-term obligations?

Its current ratio is 11.24 — current assets exceed current liabilities.

Where does Delcath Systems's balance sheet data come from?

Every line is extracted from Delcath Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Delcath Systems DCTH Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Cash and cash equivalents	$41.3M+223%	$2K-100.0%	$41.8M+403%	$34.41M+133%	$12.78M+8.6%
Short-term investments	$47.99M+4.0%	$47.58M+129%	$47.1M+730%	$46.58M—	$46.12M—
Accounts receivable, net	$14.16M+1.6%	$11.74M+7.8%	$13.75M+98.3%	$15.84M+325%	$13.94M+791%
Inventories	$9.81M+37.5%	$10.25M+47.9%	$10.75M+61.8%	$10.52M+66.6%	$7.13M+96.3%
Raw materials	$5.77M+49.3%	$6.48M+68.3%	$7.04M+94.6%	$7.23M+101%	$3.86M+189%
Work in process	$3.09M+35.9%	$2.81M+24.3%	$2.71M+20.3%	$2.34M+8.2%	$2.27M+14.6%
Finished goods	$954K-4.4%	$966K+17.2%	$994K+28.9%	$957K+69.7%	$998K+216%
Prepaid expenses and other current assets	$7M+59.9%	$6.5M+140%	$7.21M+449%	$6.12M+322%	$4.38M+243%
Income taxes receivable	$523K—	$696K—	$1.1M—	$489K—	——
Accrued investment income	$581K+53.3%	$499K+299%	$709K+7,778%	$448K—	$379K—
Total current assets	$120.27M+42.6%	$119.53M+62.1%	$120.62M+318%	$113.48M+261%	$84.35M+151%
Property and equipment, net	$3.66M+87.4%	$3.17M+76.9%	$2.72M+57.0%	$2.4M+68.8%	$1.95M+46.3%
Accumulated depreciation	$5.34M+6.5%	$5.25M+5.9%	$5.17M+4.4%	$5.1M-0.4%	$5.02M-1.6%
Operating lease right-of-use assets	$907K-10.7%	$936K-9.9%	$965K-9.8%	$993K-9.1%	$1.02M-9.0%
Total assets	$124.84M+43.0%	$123.63M+61.4%	$124.3M+292%	$116.88M+245%	$87.32M+142%
Accrued expenses	$2.81M+51.0%	$4.25M-16.3%	$3.43M+12.3%	$2.89M+25.6%	$1.86M+18.8%
Operating lease liabilities, current	$92K-16.4%	$101K-3.8%	$110K+2.8%	$116K+12.6%	$110K+7.8%
Total current liabilities	$10.7M+102%	$10.95M+78.2%	$8.01M-62.9%	$10.44M-15.1%	$5.29M-60.4%
Operating lease liabilities, non-current	$815K-10.0%	$835K-10.5%	$855K-11.2%	$877K—	$906K—
Operating Lease Liabilities (Total)	$907K-10.7%	$936K-9.8%	$965K-9.8%	$993K-9.1%	$1.02M-9.1%
Other non-current liabilities	$615K-31.4%	$628K-18.0%	$582K+3.4%	$578K-8.5%	$896K-6.9%
Total liabilities	$845K-24.1%	$864K-11.3%	$808K-94.1%	$802K-95.2%	$1.11M-84.4%
Preferred stock	$0—	$0—	$0—	$0—	$0—
Common stock	80M0.0%	80M+24,069%	80M0.0%	80M0.0%	80M0.0%
Additional paid-in capital	$641.71M+5.2%	$639.15M+6.5%	$640.57M+19.4%	$631.83M+18.3%	$609.99M+15.0%
Retained earnings	-$529.92M+0.1%	-$528.85M+0.5%	-$526.95M+0.2%	-$527.78M+0.4%	-$530.48M-2.8%
Accumulated other comprehensive income (loss)	$571K+49.9%	$575K+601%	$875K+7,855%	$592K+7,300%	$381K+143%
Total stockholders' equity	$112.71M+40.5%	$111.22M+61.8%	$114.85M+1,240%	$104.99M+2,404%	$80.23M+449%
Total liabilities and stockholders' equity	$124.84M+43.0%	$123.63M+61.4%	$124.3M+292%	$116.88M+245%	$87.32M+142%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)	$41.31M+223%	$43.45M+34.1%	$41.81M+403%	$34.42M+133%	$12.78M+8.2%
Cash, Cash Equivalents, and Marketable Securities	——	——	——	——	——
Available For Sale Securities Debt Securities Current	$47.99M+4.0%	$47.58M+129%	$47.1M+730%	$46.58M—	$46.12M—
Other Inventory, Net	——	——	——	——	——
Net Investment in Lease	$907K-10.7%	$936K-9.9%	$965K-9.8%	$993K-9.1%	$1.02M-9.0%
Operating lease right-of-use assets	$907K-10.7%	$936K-9.9%	$965K-9.8%	$993K-9.1%	$1.02M-9.0%
Property, plant and equipment at cost	$9M+29.2%	$8.41M+24.8%	$7.88M+18.0%	$7.5M+14.7%	$6.97M+8.4%
Operating Lease Right-of-Use Assets in Other Assets	$907K-10.7%	$936K-9.9%	$965K-9.8%	$993K-9.1%	$1.02M-9.0%
Accrued Manufacturing Costs	$2.81M+51.0%	$4.25M+22.4%	$3.43M+12.3%	$2.89M+25.6%	$1.86M+18.8%
Other Commercial Liabilities	$7.14M+101%	$8.19M+61.3%	$5.77M+1.1%	$5.6M+26.8%	$3.56M-19.0%
Accrued Liabilities, Current	$7.14M+101%	$8.19M+61.3%	$5.77M+1.1%	$5.6M+26.8%	$3.56M-19.0%
Compensation and benefits	$2.81M+51.0%	$4.25M+22.4%	$3.43M+12.3%	$2.89M+25.6%	$1.86M+18.8%
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2025 (Lessee)	——	——	——	——	——
Lease Liability Payments - Due Year Two	——	——	——	——	——
Lease Liability Payments - Due Year Three	——	——	——	——	——
Lease Liability Payments - Due Year Four	——	——	——	——	——
Lease Liability Payments - Remainder of Fiscal Year	——	——	——	——	——
Operating Lease Liability Payments Due	——	——	——	——	——
Operating Lease Liability - Undiscounted Excess Amount	——	——	——	——	——
Professional Service Fees Payable	$1.36M+322%	$736K+1,191%	$251K+43.4%	$305K+84.8%	$321K+27.4%
Contingent Consideration Liability (Non-Current)	$845K-24.1%	$864K-11.3%	$808K+2.9%	$802K—	$1.11M—
Operating Lease Liability Payments - 2026 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2027 (Lessee)	——	——	——	——	——
Operating Lease Liability Payments - 2028 (Lessee)	——	——	——	——	——
Total debt	$907K-10.7%	$936K-9.8%	$965K-68.6%	$993K-82.2%	$1.02M-88.0%
Common Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common Stock Shares Issued	34.5M+3.1%	34.7M+4.9%	35.3M+26.0%	35M+25.1%	33.4M+31.4%
Common Stock Shares Outstanding	$13.93M-56.3%	$17.39M-39.6%	$20.18M+30.6%	$35.67M+176%	$31.86M+7,258%
Convertible Preferred Stock Authorized Shares	10M0.0%	10M0.0%	10M0.0%	10M0.0%	10M0.0%
Convertible Preferred Stock Issued Shares	14.2K0.0%	14.2K0.0%	14.2K+15.0%	14.2K+15.0%	14.2K-15.6%
Convertible Preferred Stock Outstanding Shares	14.2K0.0%	14.2K0.0%	14.2K+15.0%	14.2K+15.0%	14.2K-15.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$344K+3.0%	$347K+4.8%	$353K+26.1%	$350K+25.4%	$334K+31.5%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——	——
Preferred Stock Par Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Share-Based Payment Award Options Outstanding - Number	8.6M+8.2%	7.8M+35.0%	7.7M+27.9%	8.1M+31.8%	8M+31.9%
Share-Based Payment - Unrecognized Cost of Nonvested Awards	——	——	——	——	——
Share Repurchase Authorization Limit	——	——	——	——	——
Share Repurchase Program - Amount Remaining	——	——	——	——	——
Weighted Average Exercise Price of Outstanding Options	$10.00+1.9%	$10.05+39.0%	$10.06+39.9%	$10.01+40.8%	$9.81+38.2%
Cumulative Cost Basis	$9M+29.2%	$8.41M+24.8%	$7.88M+18.0%	$7.5M+14.7%	$6.97M-54.1%
Clinical expenses	$2.1M+201%	$2.07M+236%	$1.18M+37.1%	$1.1M+161%	$697K-34.5%
Inventory	$28K+211%	$74K+68.2%	$102K+1,175%	$222K—	$9K—
Professional service fees	$1.36M+322%	$736K+1,191%	$251K+43.4%	$305K+84.8%	$321K+27.4%
Available for sale investments	——	——	——	——	——
Business Combination, Contingent Consideration, Liability	$845K-24.1%	$864K-11.3%	$808K+2.9%	$802K—	$1.11M—
Cash and cash equivalents, end of period	$41.31M+223%	$43.45M+34.1%	$41.81M+403%	$34.42M+133%	$12.78M+8.2%
Common stock, par value (in dollars per share)	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Common stock, shares authorized (in shares)	$80M0.0%	$80M0.0%	$80M0.0%	$80M0.0%	$80M0.0%
Common stock, shares issued (in shares)	$34.47M+3.1%	$34.69M+4.9%	$35.31M+26.0%	$34.96M+25.1%	$33.44M+31.4%
Common Stock, Shares, Outstanding	$34.47M+3.1%	$34.69M+4.9%	$35.31M+26.0%	$34.96M+25.1%	$33.44M+31.4%
Unrecognized compensation cost related to non-vested awards	——	——	——	——	——
ESPP withholding	$198K—	$396K—	$202K—	——	——
Interest receivable on interest rate and cross currency swaps	$581K+53.3%	$499K+299%	$709K+7,778%	$448K—	$379K—
Raw materials	$5.77M+49.3%	$6.48M+68.3%	$7.04M+94.6%	$7.23M+101%	$3.86M+189%
Lessee Operating Lease Liability Payments Due	——	——	——	——	——
Thereafter	——	——	——	——	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	——	——	——
Milestone payment unpaid	——	——	——	——	——
Pre-funded warrants outstanding (in shares)	——	——	——	——	——
Other accrued liabilities	$652K+98.8%	$437K-1.4%	$379K-51.0%	$611K-16.4%	$328K-56.1%
medac	$0—	$235K—	$225K—	——	——
Preferred Stock, Par or Stated Value Per Share	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%	$0.010.0%
Preferred Stock, Shares Authorized	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%	$10M0.0%
Preferred stock, shares designated (in shares)	——	——	——	——	——
Preferred Stock, Shares Issued	$14.19K0.0%	$14.19K0.0%	$14.19K+15.0%	$14.19K+15.0%	$14.19K-15.6%
Preferred Stock, Shares Outstanding	$14.19K0.0%	$14.19K0.0%	$14.19K+15.0%	$14.19K+15.0%	$14.19K-15.6%
Clinical trial expenses	$2.45M+103%	$2.41M+983%	$2.41M+983%	$2.41M+983%	$1.21M+444%
Prepaid Insurance	$557K+101%	$547K+240%	$180K+60.7%	$188K+29.7%	$277K+60.1%
Licenses	$538K—	$613K—	$682K—	$498K—	——
Professional services	$941K+14.6%	$804K+5.5%	$1.06M+182%	$1.25M+90.1%	$821K+147%
Software	$1.07M—	$706K—	$670K—	$404K—	——
Aggregate Intrinsic Value, Unvested	——	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$8.62M+8.2%	$7.79M+35.0%	$7.75M+27.9%	$8.08M+31.8%	$7.97M+31.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$10+1.9%	$10.05+39.0%	$10.06+39.9%	$10.01+40.8%	$9.81+38.2%
Weighted Average Exercise Price, Unvested (in dollars per share)	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	$13.93M-56.3%	$17.39M-39.6%	$20.18M+30.6%	$35.67M+176%	$31.86M+7,258%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——	——
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares	——	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——	——
Share Repurchase Program, Authorized, Amount	——	——	——	——	——
Share Repurchase Program, Remaining Authorized, Amount	——	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——	——
Unrecorded Unconditional Purchase Obligation	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Delcath Systems.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Delcath Systems's total assets?: Delcath Systems (DCTH) holds $124.8M in total assets, up 43.0% year over year.
How much debt does Delcath Systems have?: Delcath Systems carries $907.0K in total debt against $112.7M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Delcath Systems have?: Delcath Systems holds $41.3M in cash and equivalents.
Can Delcath Systems cover its short-term obligations?: Its current ratio is 11.24 — current assets exceed current liabilities.
Where does Delcath Systems's balance sheet data come from?: Every line is extracted from Delcath Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.